Companies

See how salaries can vary from company to company

Accuray Incorporated designs, develops, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the body. The company offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of various types of cancer and tumors in the body. The CyberKnife System automatically tracks, detects, and corrects for tumor and patient movement in real-time during the procedure, as well as enables the delivery of precise, high dose radiation while patients breathe normally. It also offers the TomoTherapy System,... view company details

Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops cell and gene therapies for life-threatening rare genetic diseases. Its lead programs include EB-101, an autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa; ABO-102, an adeno-associated virus-based gene therapy for Sanfilippo syndrome type A; and ABO-101 an AAV-based gene therapy for Sanfilippo syndrome type B. The company also develops ABO-202 and ABO-201, which are AAV-based gene therapies for the CLN1 and CLN3 forms of Batten disease; ABO-401 for the treatment of cystic fibrosi... view company details

Sensus Healthcare, Inc. manufactures and markets superficial radiation therapy devices to healthcare providers worldwide. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Scul... view company details

Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast growth factor 23 for the treatment of X-linked hypophosphatemia; and Mepsevii, an enzyme replacement therapy for the treatment of children and adults with Mucopolysaccharidosis VII. The company is also developing small-molecule pipeline comprising UX007, a synthetic triglyceri... view company details

Eyas Landing's mission is to provide family-centered and evidence-based pediatric therapy services for children and their families. Our primary goal is to deliver relationship-based interventions within the most natural environments and to empower families to reach their full potential. To achieve this goal, our highly educated, compassionate staff dedicates time and expertise to create experiences that maximize therapeutic outcomes. The strength, determination, and perseverance of our clients are evident as they succeed in therapy, and ultimately in their daily routines. view company details

Inspire Medical Systems, Inc. has developed the world's first fully implanted neurostimulation device approved by the FDA for the treatment of Obstructive Sleep Apnea (OSA). The Inspire system uses well-established neurostimulation technologies and incorporates a proprietary algorithm that stimulates key airway muscles based on a patient's unique breathing patterns. Inspire therapy is designed to reduce OSA severity and improve quality of life for patients living with this challenging condition. Inspire therapy works inside your body, and with your natural breathing process. It might be right ... view company details

Gemphire Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of dyslipidemia and nonalcoholic fatty liver disease (NAFLD/NASH). The company is developing gemcabene, a novel, once-daily, and oral therapy for dyslipidemia conditions where patients are unable to reach their lipid lowering goals, including patients already receiving maximally tolerated statin therapy. It also completed three Phase IIb clinical trials for gemcabene in homozygous familial hypercholesterolemia (HoFH) and hypercholesterolemia, including h... view company details

Novo Integrated Sciences, Inc. provides primary healthcare services. The company offers physiotherapy, chiropractic care, occupational therapy, eldercare, laser therapeutics, massage therapy, acupuncture, chiropodist, neurological functions, kinesiology, and dental services. Its healthcare services and protocols are directed at assessment, treatment, management, rehabilitation, and prevention through its 14 corporate owned clinics, 150 affiliate clinics, retirement homes, long-term care facilities, and institutional locations in Canada. The company headquartered in Bellevue, Washington. view company details

New Glarus Home is a stunning 30-acre Continuing Care Retirement Community (CCRC), located in New Glarus, WI, just 30-minutes south of Madison. We offer several levels of care ranging from independent living to comprehensive skilled nursing care, as well as, outpatient Therapy Services from Aegis Therapies. We are currently in the process of constructing an addition to our skilled nursing facility to enhance our Therapy and Short Term Rehabilitation Programs and to add much needed square footage to our facility. This expansion is estimated to be completed Summer of 2017. The New Glarus Home fo... view company details

Axovant Gene Therapies Ltd., a clinical-stage gene therapy company, focuses on developing a pipeline of product candidates for debilitating neurological and neuromuscular diseases. The company's current pipeline of gene therapy candidates targets GM1 gangliosidosis, GM2 gangliosidosis, Parkinson's disease, oculopharyngeal muscular dystrophy, amyotrophic lateral sclerosis, and frontotemporal dementia. The company was formerly known as Axovant Sciences Ltd. The company was founded in 2014 and is based in New York, New York. Axovant Gene Therapies Ltd. operates as a subsidiary of Roivant Sciences... view company details

Sorrento Therapeutics, Inc., a clinical stage biotechnology company, primarily engages in the discovery and development of therapies focused on oncology and the treatment of chronic cancer pain worldwide. It offers resiniferatoxin, a non-opioid-based TRPV1 agonist neurotoxin for the treatment of intractable pain treatment; and ZTlido, a lidocaine delivery system for the treatment of postherpetic neuralgia. The company also develops CD38 Directed chimeric antigen receptor T-cell therapy (CAR-T) for the treatment of multiple myeloma, as well as for amyloidosis and graft-versus-host diseases; car... view company details

We are a full-service animal hospital offering the highest quality veterinary medicine in a pet-friendly atmosphere in Shawnee, Oklahoma. In addition to diagnostic and preventative services, our hospital is equipped with digital radiography, in-house labs, endoscopy, cold laser therapy, ultrasound and portable x-ray. We also offer TightRope CCL repairs, shockwave therapy, ophthalmology services and exotic animal care. We're focused on making sure our hospital has the right tools to allow our doctor and medical staff the ability to provide excellent service and care. view company details

ViewRay, Inc. designs, manufactures, and markets radiation therapy systems. The company offers MRIdian, a magnetic resonance image-guided radiation therapy system to image and treat cancer patients. Its MRIdian integrates MRI technology, radiation delivery, and proprietary software to see the soft tissues, shape the dose to accommodate for changes in anatomy, and strike the target using real-time targeting throughout the treatment. ViewRay, Inc. serves university research and teaching hospitals, community hospitals, private practices, government institutions, and freestanding cancer centers. T... view company details

Hash Labs Inc. develops solutions for fintech industry. It develops a mobile application that will convert gold into a price-stable and scalable, as well as backed by the physical gold cryptocurrency asset using hashgraph digital ledger technology. The company was formerly known as Tech Town Holdings Inc. and changed its name to Hash Labs Inc. in March 2018. Hash Labs Inc. was founded in 2005 and is based in Miami, Florida. view company details

Lutheran Social Services of Northwestern Ohio provides human services that will strengthen the mental, moral, physical, social and spiritual well-being of those who seek this agency's services. We are proud of our past, prepared for the present and passionate about the future as a faith-based Lutheran agency serving the needs of all people. Lutheran Social Services of Northwestern Ohio is accredited by the Council on Accreditation (COA). To learn more about COA, please visit www.COAnet.org. view company details

Since 1880, Three Rivers Youth (TRY) has been serving abused, neglected, runaway and homeless youth and their families in Western Pennsylvania. A private non-profit agency, TRY provides a spectrum of educational, vocational, residential, outpatient and in-home programs to youth who are victims of physical and sexual abuse, neglect, abandonment, school failure, early pregnancy and drug and alcohol use. view company details

U.S. Stem Cell, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of autologous cellular therapies for the treatment of chronic and acute heart damage, and vascular and autoimmune diseases in the United States and internationally. Its lead product candidates include MyoCell, a clinical therapy designed to populate regions of scar tissue within a patient's heart with autologous muscle cells or cells from a patient's body for enhancing cardiac function in chronic heart failure patients; and AdipoCell, a patient-derived cell therapy for the treatment of a... view company details

Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates through two segments, Oncology Systems and Proton Solutions. The Oncology Systems segment offers hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy, as well as related quality assurance equipment. Its prod... view company details

American Shared Hospital Services leases radiosurgery and radiation therapy equipment to health care providers in the United States. The company offers radiosurgery equipment for the Gamma Knife stereotactic radiosurgery, a non-invasive procedure to treat malignant and benign brain tumors, and arteriovenous malformations, as well as for trigeminal neuralgia. It also provides image guided radiation therapy systems that integrate imaging and detection components into an accelerator, which allows clinicians to plan treatment, verify positioning, and deliver treatment. In addition, the company off... view company details

Spark Therapeutics, Inc. focuses on the development of gene therapy products for patients suffering from debilitating genetic diseases. Its products include LUXTURNA (voretigene neparvovec) for the treatment of patients with confirmed biallelic RPE65 mutation-associated retinal dystrophy and viable retinal cells. The company's gene therapy product candidates comprise SPK-8011 and SPK-8016 for hemophilia; SPK-7001 for choroideremia; and SPK-9001 for hemophilia B. It is also developing other liver-directed gene therapies, including SPK-3006 for Pompe disease; and neurodegenerative disease produc... view company details